HighFLO Study - HighLife Trans-septal Mitral Valve Replacement (TSMVR) Feasibility Study of the Open Cell CLARITY Valve

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2031

Conditions
Mitral Regurgitation
Interventions
DEVICE

CLARITY

Trans-septal mitral valve replacement

Trial Locations (14)

31076

RECRUITING

Cliniue Pasteur, Toulouse

44000

RECRUITING

Centre Hospitalo - Univ de Nantes, Nantes

59000

RECRUITING

CHU Lille, Lille

Unknown

RECRUITING

Wesley Hospital, Auchenflower

RECRUITING

Mount Hospital, Perth

TERMINATED

Macquarie University Hospital, Sydney

RECRUITING

AZ St. Jan - Brugge, Bruges

RECRUITING

UZ Leuven, Leuven

RECRUITING

CHU de Rennes, Rennes

RECRUITING

Deutsches Herzzentrum Munchen, Munich

RECRUITING

University Hospital Ulm, Ulm

RECRUITING

Medical University of Silesia, Katowice

RECRUITING

Medical University of Warsaw, Warsaw

RECRUITING

Brighton and Sussex University Hospital, Brighton

All Listed Sponsors
lead

HighLife SAS

INDUSTRY